A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis.

A Study to Evaluate the Clinical and Microbial Efficacy of 0.6% ISV-403 Compared to Vehicle in the Treatment of Bacterial Conjunctivitis.

Evaluation of the clinical and microbial efficacy of 0.6% ISV-403, compared to vehicle in the treatment of bacterial conjunctivitis.

Inclusion Criteria:

• Must have a diagnosis of acute bacterial conjunctivitis and exhibit purulent conjunctival discharge and redness in at least one eye.
• Females of childbearing potential must utilized reliable contraceptive methods and have a negative pregnancy test.

Exclusion Criteria:

• Pregnant or nursing females.
• Known hypersensitivity to fluoroquinolones or to any of the study ingredients.
• Use of any antibiotic within 72 hours of treatment.
• Any disease or condition that could interfere with the safety and efficacy evaluations of the study medications.
• Participation in an ophthalmic drug or device research study within 30 days prior to entry into the study.